The novel approach of this peptide represents a exciting advance in the handling of the condition. Distinct from existing therapies, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide503947.thekatyblog.com/40192264/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment